Lesion genesis in a subset of patients with multiple sclerosis: A role for innate immunity?

Brain

Volumn 130, Issue 11, 2007, Pages 2800-2815

  Marik, Christina ^a   Felts, Paul A ^b   Bauer, Jan ^a   Lassmann, Hans ^a,c   Smith, Kenneth J ^b  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c Medical University of Vienna   (Austria)

Author keywords

Fibrin; Innate immunity; Lesion development; Lipopolysaccharide; Microglial activation; Multiple sclerosis

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; FIBRIN; LIPOPOLYSACCHARIDE; MYELOPEROXIDASE; NITRIC OXIDE SYNTHASE;

ADULT; AGED; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AXONAL INJURY; BRAIN DAMAGE; BRAIN EDEMA; BRAIN REGION; CELL ACTIVATION; CELL INFILTRATION; CONTROLLED STUDY; DEMYELINATION; DISEASE COURSE; DISEASE MARKER; FEMALE; HEMISPHERE; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPOXIA; IMMUNOCYTOCHEMISTRY; INNATE IMMUNITY; MACROPHAGE; MALE; MICROGLIA; MULTIPLE SCLEROSIS; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RECURRENT DISEASE; REMISSION; T LYMPHOCYTE; TISSUE INJURY; UPREGULATION; WHITE MATTER;

EID: 35649018602     PISSN: 00068950     EISSN: 14602156     Source Type: Journal    
DOI: 10.1093/brain/awm236     Document Type: Article

References (48)

1. Aboul-Enein F, Rauschka H, Kornel B, Stadelmann C, Stefferl A, Brück W, et al. Preferential loss of myelin associated glycoprotein reflects hypoxialike white matter damage in stroke and inflammatory brain diseases. J Neuropath Exp Neurol 2003; 62: 25-33.
2. 377-395 peptide inhibits microglia activation and suppresses relapsing paralysis in central nervous system autoimmune disease. J Exp Med 2007; 204: 571-82.
3. Akassoglou K, Adams RA, Bauer J, Mercado P, Tseveleki V, Lassmann H, et al. Fibrin depletion decreases inflammation and delays the onset of demyelination in a tumor necrosis factor transgenic mouse model for multiple sclerosis. Proc Natl Acad Sci USA 2004; 101: 6698-703.
4. Altieri DC, Bader R, Mannucci PM, Edgington TS. Oligospecificity of the cellular adhesion receptor Mac-1 encompasses an inducible recognition specificity for fibrinogen. J Cell Biol 1988; 107: 1893-900.
5. Babinski J. Recherches sur l0anatomie pathologique de la sclerose en plaque et etude comparative des diverses varietes de la scleroses de la moelle. Arch Physiol (Paris) 1885; 5-6: 186-207.
6. Barnett MH, Prineas JW. Relapsing and remitting multiple sclerosis: pathology of the newly forming lesion. Ann Neurol 2004; 55: 458-68.
7. Bergeron M, Gidday JM, Yu AY, et al. Role of hypoxia-inducible factor 1 in hypoxia-induced ischemic tolerance in neonatal rat brain. Ann Neurol 2000; 48: 285-96.
8. Bernaudin M, Tang Y, Reilly M, et al. Brain genomic response following hypoxia and re-oxygenation in the neonatal rat. Identification of genes that might contribute to hypoxia-induced ischemic tolerance. J Biol Chem 2002; 277: 39728-38.
9. Bien CG, Bauer J, Deckwerth TL, Wiendl H, Deckert M, Wiestler OD, et al. Destruction of neurons by cytotoxic T cells: a new pathogenic mechanism in Rasmussen's encephalitis. Ann Neurol 2002; 51: 311-8.
10. Bitsch A, Wegener C, da Costa C, Bunkowski S, Reimers CD, Prange HW, et al. Lesion development in Marburg's type of acute multiple sclerosis: from inflammation to demyelination. Mult Scler 1999; 5: 138-46.
11. Booss J, Esiri MM, Tourtellotte WW, Mason DY. Immunohistological analysis of T lymphocyte subsets in the central nervous system in chronic progressive multiple sclerosis. J Neurol Sci 1983; 62: 219-32.
12. Buss A, Schwab ME. Sequential loss of myelin proteins during Wallerian degeneration in the rat spinal cord. Glia 2003; 42: 424-32.
13. Christians ES, Yan LJ, Benjamin IJ. Heat shock factor-1 and heat shock proteins: critical partners in protection against acute cell injury. Crit Care Med 2002; 30: S43-50.
14. Dawson JW. The histology of disseminated sclerosis. Trans R Soc 1916; 50: 517-40.
15. De Groot CJA, Bergers E, Kamphorst W, Ravid R, Polman F, Barkhof F, et al. Post-mortem MRI-guided sampling of multiple sclerosis brain lesions. Increased yield of active demyelinating and (p)reactive lesions. Brain 2001; 124: 1635-45.
16. Deininger MH, Meyermann R, Schlüsener HJ. The allograft inflammatory factor-1 family of proteins. FEBS Lett 2002; 514: 115-21.
17. Dobersen MJ, Hammer JA, Noronha AB, et al. Generation and characterization of mouse monoclonal antibodies to myelin associated glycoprotein (MAG). Neurochem Res 1985; 10: 499-513.
18. El Mezayen R, El Gazzar M, Seeds MC, McCall CE, Dreskin SC, Nicolls MR. Endogenous signals released from necrotic cells augment inflammatory responses to bacterial endotoxin. Immunol Lett 2007; 31: 36-44.
19. Esiri MM, Reading MC. Macrophage populations associated with multiple sclerosis plaques. Neuropathol Appl Neurobiol 1987; 13: 451-65.
20. Felts PA, Woolston AM, Fernando HB, Asquith S, Gregson NA, Mizzi OJ, et al. Inflammation and primary demyelination induced by the intraspinal injection of lipopolysaccharide. Brain 2005; 128: 1649-66.
21. Ferguson B, Matyszak MK, Esiri MM, Perry VH. Axonal damage in acute multiple sclerosis lesions. Brain 1997; 120: 393-9.
22. Filippi M, Rocca MA, Martino G, Horsfield MA, Comi G. Magnetization transfer changes in the normal appearing white matter precede the appearance of enhancing lesions in patients with multiple sclerosis. Ann Neurol 1998; 43: 809-14.
23. Flick MJ, Du X, Witte DP, Jirouskova DA, Busuttil SJ, Plow EF, et al. Leukocyte engagement of fibrin(ogen) via the integrin receptor alphaMbeta2/Mac-1 is critical for host inflammatory response in vivo. J Clin Invest 2004; 113: 1596-606.
24. Gay FW, Drye GW, Dick GWA, Esiri MM. The application of multifactorial cluster analysis in the staging of plaques in early multiple sclerosis: identification and characterization of the primary demyelinating lesion. Brain 1997; 120: 1461-83.
25. Gveric D, Herrera B, Petzold A, Lawrence DA, Cuzner ML. Impaired fibrinolysis in multiple sclerosis: a role for tissue plasminogen activator inhibitors. Brain 2003; 126: 1590-8.
26. Jung DY, Lee H, Jung BY, Ock J, Lee WH, Suk K. TLR4, but not TLR2, signals autoregulatory apoptosis of cultured microglia: a critical role of IFN-beta as a decision maker. J Immunol 2005; 164: 154-60.
27. Kutzelnigg A, Lucchinetti CF, Stadelmann C, Brück W, Rauschka H, Bergmann M, et al. Cortical demyelination and diffuse white matter injury in multiple sclerosis. Brain 2005; 128: 2705-12.
28. Linington C, Bradl M, Lassmann H, et al. Augmentation of demyelination in rat acute allergic encephalomyelitis by circulating antibodies against a myelin oligodendrocyte glycoprotein. Am J Pathol 1988; 130: 443-54.
29. Lucchinetti C, Brück W, Parisi J, Scheithauer B, Rodriguez M, Lassmann H. Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination. Ann Neurol 2000; 47: 707-17.
30. Lucchinetti CF, Mandler RN, McGavern D, Bruck W, Gleich G, Ransohoff RM, et al. A role for humoral mechanisms in the pathogenesis of Devic's neuromyelitis optica. Brain 2002; 125: 1450-61.
31. Marburg O. Die sogenannte "akute Multiple Sklerose". Jahrb Psychiatrie 1906; 27: 211-312.
32. Narayanan PA, Doyle TJ, Lai D, Wolinski JS. Serial proton magnetic resonance spectroscopic imaging, contrast-enhanced magnetic resonance imaging, and quantitative lesion volumetry in multiple sclerosis. Ann Neurol 1998; 43: 56-71.
33. Patrikios P, Stadelmann C, Kutzelnigg A, Rauschka H, Schmidbauer M, Laursen H, et al. Remyelination is extensive in a subset of multiple sclerosis patients. Brain 2006; 129: 3165-72.
34. Prineas JW. The neuropathology of multiple sclerosis. In: Koetsier JC, editor. Handbook of clinical neurology, Vol. 47. New York: Elsevier; 1985; p. 337-95.
35. Rindfleisch E. Histologisches Detail zur grauen Degeneration von Gehirn und Rückenmark. Arch Pathol Anat Physiol Klin Med (Virchow) 1863; 26: 474-83.
36. Schrijver IA, van Meurs M, Melief M-J, Wim-Ang C, Bujevac D, Ravid R, et al. Bacterial petidoglycan and immune reactivity in the central nervous system in multiple sclerosis. Brain 2001; 124: 1544-54.
37. Sharp FR, Bergeron M, Bernaudin M. Hypoxia-inducible factor in brain. Adv Exp Med Biol 2001; 502: 273-91.
38. Sharp FR, Bernaudin M. HIF1 and oxygen sensing in the brain. Nature Rev Neurosci 2004; 5: 437-48.
39. Silver NC, Tofts PS, Symms MR, Barker GJ, Thompson AJ, Miller DH. Quantitative contrast-enhanced magnetic resonance imaging to evaluate blood-barin barrier integrity in multiple sclerosis. A preliminary study. Mult Scler 2001; 7: 75-82.
40. Smiley ST, King JA, Hancock WW. Fibrinogen stimulates macrophage chemokine secretion through toll-like receptor 4. J Immunol 2001; 167: 2887-94.
41. Stadelmann C, Ludwin S, Tabira T, Guseo A, Lucchinetti CF, Leel-Össy L, et al. Tissue preconditioning may explain concentric lesions in Balo's type of multiple sclerosis. Brain 2005; 128: 979-87.
42. Stam NJ, Vroom TM, Peters PJ, Pastoors EB, Ploegh HL. HLA-Aand HLA-B-specific monoclonal antibodies reactive with free heavy chains in western blots, in formalin-fixed, paraffin-embedded tissue sections and in cryo-immuno-electron microscopy. Int Immunol 1990; 2: 113-25.
43. Storch MK, Stefferl A, Brehm U, Weissert R, Wallström E, Kerschensteiner M, et al. Autoimmunity to myelin oligodendrocyte glycoprotein in rats mimics the spectrum of multiple sclerosis pathology. Brain Pathol 1998a; 8: 681-94.
44. Trapp BD, Peterson J, Ransohoff RM, Rudick R, Mork S, Bo L. Axonal transection in the lesions of multiple sclerosis. N Engl J Med 1998; 338: 278-85.
45. Traugott U, Reinherz EL, Raine CS. Multiple sclerosis. Distribution of T cells, T cell subsets and Ia-positive macrophages in lesions of different ages. J Neuroimmunol 1983; 4: 201-21.
46. Visser L, Jan de Heer H, Boven LA, van Riet D, van Meurs M, Melief MJ, et al. Proinflammatory bacterial peptidoglycan as a cofactor for the development of central nervous system autoimmune disease. J Immunol 2005; 174: 808-16.
47. Weaver LK, Pioli PA, Wardwell K, Vogel SN, Guyre PM. Up-regulation of human monocyte CD163 upon activation of cell surface Toll.like receptors. J Leukocyte Biol 2007; 81: 663-71.
48. Wuerfel J, Bellmann-Strobl J, Brunecker P, Aktas O, McFarland H, Villringer A, et al. Changes in cerebral perfusion precede plaque formation in multiple sclerosis: a longitudinal perfusion MRI study. Brain 2004; 127: 111-9.